| Financial Year |
March 31 2023 |
| Monetary Funds |
258,784,458.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
85,814,569.40 |
| Advances to Suppliers |
13,125,899.09 |
| Other Receivables |
5,664,836.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,631,908.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,262,267.00 |
| Total Current Assets |
524,283,938.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,192,381.95 |
| Investment Properties |
-- |
| Fixed Assetes |
852,737,008.18 |
| Under-construction Projects |
18,416,215.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
181,298,831.25 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,599,803.58 |
| R&D expenses |
-- |
| Goodwill |
397,571.49 |
| Long-Term Deferred and Prepaid Expenses |
1,359,255.65 |
| Deferred Income Tax Assets |
6,209,386.19 |
| Other Non-Current Assets |
69,421,560.46 |
| Sub-Total of Non-Current Assets |
1,338,534,392.04 |
| Total Assets |
1,862,818,330.29 |
| Short-Term Loans |
167,439,413.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
197,959,077.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,592,773.49 |
| Taxes Payable |
9,849,976.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,732,028.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,677,461.25 |
| Other Current Liabilities |
2,799,544.32 |
| Sub-Total of Current Liabilities |
501,631,520.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,114,541.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
60,194,121.09 |
| Total Liabilities |
561,825,641.53 |
| Paid-In Capital(Or Share Stock) |
157,350,000.00 |
| Capital Surplus |
319,405,903.55 |
| Surplus Reserve |
113,041,714.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
687,869,256.04 |
| Minority Stockholder's Interest |
23,325,815.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,277,666,873.65 |
| Owner's Equity（Stockholder's Equity） |
1,300,992,688.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,862,818,330.29 |
